HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.

AbstractOBJECTIVE:
X-linked Charcot-Marie-Tooth disease (CMT1X) is a common inherited neuropathy caused by mutations in the GJB1 gene encoding the gap junction protein connexin32 (Cx32). Clinical studies and disease models indicate that neuropathy mainly results from Schwann cell autonomous, loss-of-function mechanisms; therefore, CMT1X may be treatable by gene replacement.
METHODS:
A lentiviral vector LV.Mpz-GJB1 carrying the GJB1 gene under the Schwann cell-specific myelin protein zero (Mpz) promoter was generated and delivered into the mouse sciatic nerve by a single injection immediately distal to the sciatic notch. Enhanced green fluorescent protein (EGFP) reporter gene expression was quantified and Cx32 expression was examined on a Cx32 knockout (KO) background. A gene therapy trial was performed in a Cx32 KO model of CMT1X.
RESULTS:
EGFP was expressed throughout the length of the sciatic nerve in up to 50% of Schwann cells starting 2 weeks after injection and remaining stable for up to 16 weeks. Following LV.Mpz-GJB1 injection into Cx32 KO nerves, we detected Cx32 expression and correct localization in non-compact myelin areas where gap junctions are normally formed. Gene therapy trial by intraneural injection in groups of 2-month-old Cx32 KO mice, before demyelination onset, significantly reduced the ratio of abnormally myelinated fibers (p = 0.00148) and secondary inflammation (p = 0.0178) at 6 months of age compared to mock-treated animals.
INTERPRETATION:
Gene delivery using a lentiviral vector leads to efficient gene expression specifically in Schwann cells. Restoration of Cx32 expression ameliorates nerve pathology in a disease model and provides a promising approach for future treatments of CMT1X and other inherited neuropathies.
AuthorsIrene Sargiannidou, Alexia Kagiava, Stavros Bashiardes, Jan Richter, Christina Christodoulou, Steven S Scherer, Kleopas A Kleopa
JournalAnnals of neurology (Ann Neurol) Vol. 78 Issue 2 Pg. 303-16 (Aug 2015) ISSN: 1531-8249 [Electronic] United States
PMID26010264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 American Neurological Association.
Chemical References
  • Connexins
  • RNA, Messenger
Topics
  • Animals
  • Charcot-Marie-Tooth Disease (genetics, metabolism)
  • Connexins (genetics)
  • Disease Models, Animal
  • Genetic Therapy
  • Genetic Vectors
  • Lentivirus
  • Mice
  • Mice, Knockout
  • RNA, Messenger (metabolism)
  • Schwann Cells (metabolism)
  • Sciatic Nerve (metabolism)
  • Gap Junction beta-1 Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: